Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis.
Chemokines are low-molecular-weight chemotactic cytokines that have been shown to play a central role in the perivascular transmigration and accumulation of specific subsets of leukocytes at sites of tissue damage. Using in situ hybridization (ISH), we investigated the mRNA induction of macrophage inflammatory protein 2 (MIP-2), MIP-1alpha, monocyte chemoattractant protein 1 (MCP-1), and RANTES. Challenge of infant rats' brains with Haemophilus influenzae type b intraperitoneally resulted in the time-dependent expression of MIP-2, MIP-1alpha, MCP-1, and RANTES, which was maximal 24 to 48 h postinoculation. Immunohistochemistry showed significant increases in neutrophils and macrophages infiltrating the meninges, the ventricular system, and the periventricular area. The kinetics of MIP-2, MIP-1alpha, MCP-1, and RANTES mRNA expression paralleled those of the recruitment of inflammatory cells and disease severity. Administration of anti-MIP-2 or anti-MIP-1alpha antibodies (Abs) resulted in significant reduction of neutrophils. Administration of anti-MCP-1 Abs significantly decreased macrophage infiltration. Combined studies of ISH and immunohistochemistry showed that MIP-2- and MIP-1alpha-positive cells were neutrophils and macrophages. MCP-1-positive cells were neutrophils, macrophages, and astrocytes. Expression of RANTES was localized predominantly to resident astrocytes and microglia. The present study indicates that blocking of MIP-2 or MIP-1alpha bioactivity in vivo results in decreased neutrophil influx. These data are also the first demonstration that the C-C chemokine MIP-1alpha is involved in neutrophil recruitment in vivo.
Diab
A
A
Divisions of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden. Asim.Diab@cnsf.ki.se
Abdalla
H
H
Li
H L
HL
Shi
F D
FD
Zhu
J
J
Höjberg
B
B
Lindquist
L
L
Wretlind
B
B
Bakhiet
M
M
Link
H
H
D000818:Animals; D001483:Base Sequence; D002490:Central Nervous System / Q000276:immunology / Q000473:pathology; D018932:Chemokine CCL2 / Q000235:genetics / Q000276:immunology; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D018946:Chemokine CCL5 / Q000235:genetics / Q000276:immunology; D054426:Chemokine CXCL2; D002630:Chemotactic Factors / Q000037:antagonists & inhibitors* / Q000276:immunology*; D002634:Chemotaxis, Leukocyte; D015342:DNA Probes / Q000235:genetics; D006192:Haemophilus Infections / Q000276:immunology / Q000473:pathology; D019741:Haemophilus influenzae type b / Q000276:immunology / Q000472:pathogenicity; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D019402:Macrophage Inflammatory Proteins / Q000037:antagonists & inhibitors* / Q000276:immunology*; D008264:Macrophages / Q000276:immunology / Q000473:pathology; D016920:Meningitis, Bacterial / Q000276:immunology* / Q000473:pathology; D015846:Monokines / Q000037:antagonists & inhibitors* / Q000276:immunology*; D009500:Neutralization Tests; D009504:Neutrophils / Q000276:immunology* / Q000473:pathology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley
D018932:Chemokine CCL2; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D018946:Chemokine CCL5; D054426:Chemokine CXCL2; D002630:Chemotactic Factors; D015342:DNA Probes; D019402:Macrophage Inflammatory Proteins; D015846:Monokines; D012333:RNA, Messenger